Computer projection facilities (Powerpoint-Presentations) will be available in the meeting rooms. Presenting authors will receive all technical information and instructions prior to the Congress in order to ensure the smooth running of sessions.
FC1 Psoriasis and Related
Thursday, 17 May 2007
8.30 – 10.00 Hall I
Chairs: M. Schön (Würzburg, Germany), M. Boffa (Floriana, Malta)
| 8.30 | FC1.1 | In vitro affinity and neutralising potency of four anti-tumour necrosis factor-α agents: Certolizumab pegol, adalimumab, etanercept and infliximab. A. Henry, G. Fossati, P. Stephens, A. Nesbitt, D. Brown (Slough, UK) |
| 8.39 | FC1.2 | Efficacy of certolizumab pegol, a PEGylated Fab´ fragment of an anti- α monoclonal antibody, in patients previously exposed to biologicals: Preliminary results of a randomised, placebo-controlled, phase II clinical trial in psoriasis. J.-P. Ortonne, C. Tasset, K. Reich (Nice, France) |
| 8.48 | FC1.3 | Infliximab safety: Findings from the Japanese postmarketing surveillance trial. O. Dabbous, Y. Tatsuki, M Rahman, K. Gilmer, R. Arjunji, M. Togo, T. Suzuki (Horsham, USA) |
| 8.57 | FC1.4 | Under-treatment of psoriasis. E. Horn, V. Patel, K. Fox, F. Dann, C. Chiou, M. Lebwohl (Portland, USA) |
| 9.06 | FC1.5 | Switch from etanercept to efalizumab in a case of severe plaque psoriasis L. Zappalà, A. Musumeci, G. Castelli (Syracusa, Italy) |
| 9.15 | FC1.6 | Echocardiographic findings in psoriatic patients. I. Janusz, N. Roszczyk, L. Markuszewski, T. Grycewicz, R. Pietruszynski R, J. Narbutt, A. Sysa-Jedrzejowska, A. Zalewska (Lodz, Poland) |
| 9.24 | FC1.7 | Management of skin toxicity to epidermal growth factor receptor inhibitors using an algorithmic approach V. Pacifico, N. Martin, S.E. Lai, M. Aneja, S. Ortiz, D. Innocenzi, G. Micali, D.P. West, M.E. Lacouture (Chicago, USA) |
| 9.33 | FC1.8 | D vitamin production after UVB exposure of different skin areas. A. Osmancevic, K. Landin-Wilhelmsen, O. Larkö, A.L. Krogstad (Gothenburg, Sweden) |
| 9.42 | FC1.9 | Overexpression of VEGFRs on keratinocytes in psoriasis: Regulated by calcium independent of VEGF. M. Zheng, X.Y. Man, X.-H. Yang, S.-Q. Cai, Z.-Y. Bu (Hangzhou, China) |
| 9.51 | FC1.10 | Other uses of topical tacrolimus. I.M.C. Costa, M.C. Costa (Brasilia, Brazil) |
FC2 Non-Melanoma Skin Cancer
Thursday, 17 May 2007
10.15 – 11.45 Hall I
Chairs: S. Davidsson (Kopavogur, Iceland), J.P. Claudel (Tours, France)
| 10.15 | FC2.1 | Merkel Cell Carcinoma. Y. Vantuchová, I. Vejrová, R. Čuřík (Ostrava, Czech Republic) |
| 10.24 | FC2.2 | Granular cell tumour: A clinicopthological review of 16 cases. V. Serrão, I. Viana, E. Vale (Lisbon, Portugal) |
| 10.33 | FC2.3 | Dermoscopic findings of basal cell carcinomas. P. Mirjana (Belgrad, Serbia and Montenegro) |
| 10.42 | FC2.4 | Mohs micrographic surgery in baso-cellular carcinomas. L. Carvalho Leal (Rio de Janeiro, Brazil) |
| 10.51 | FC2.5 | The status and new own-induced enhancements of mohs micrographic surgery in Wroclaw-Poland. A. Bieniek, M. Cisło, M. Barancewicz-Łosek, Z. Woźniak, G. Szybejko-Machaj, D. Okulewicz-Gojlik, &. Matusiak, A. Salwa, Z. Kobierzyńska, E. Pieczaba (Wroclaw, Poland) |
| 11.00 | FC2.6 | A randomized placebo-controlled trial of orally administered fosfluridine tidoxil in actinic keratoses – a systemic approach. T. Forschner, E. Boehm, J. Rowert, S. Astner, D. Kruger-Corcoran, A. Maltusch, A. Pinta-Lange, E. Stockfleth (Berlin, Germany) |
| 11.09 | FC2.7 | Effects of topical delta-Aminilevulinic acid and blue light photodynamic therapy [ALA-PDT] on the incidence of non-melanoma skin cancer [NMSC] and Actinic Keratoses [AKs] and utilization of dermatological care within Boston VA Healthcare System. N. Konnikov, O. Kozyreva, E. Lawler (Boston, USA) |
| 11.18 | FC2.8 | Fluorescence-remission-sensoring of skin tumours. U. Wollina, C. Nelskamp, A. Scheibe, D. Fassler, W.-D. Schmidt (Dresden, Germany) |
| 11.27 | FC2.9 | Polymorphic light eruption and skin cancer prevalence, is one protective against the other? S. Lembo, J. Fallon, P. O'Kelly, G.M. Murphy (Dublin, Ireland) |
| 11.36 | FC2.10 | Early treatment of haemangioma in childhood using intense pulsed light. M. Drosner (Munich, Germany) |
FC3 Cosmetic and Miscellaneous
Thursday, 17 May 2007
15.00 – 16.30 Hall J565
Chairs: D. Roseeuw (Brussels, Belgium), E.-M. Kokoschka (Vienna, Austria)
| 15.00 | FC3.1 | Calciphylaxis. E. Cohen Sabban, B. Rigo, D. Wright, Y. Mohr, J. Laccassagne, C. Llopis Fernandez, N. Pietropaolo, C. Horacio (Buenos Aires, Argentina) |
| 15.09 | FC3.2 | A topical antioxidant solution containing vitamins C and E stabilized with ferulic acid protects skin from sunlight damage and DNA mutations associated with skin cancer. J.C. Murray, M.A. Iannachione, J.E. Zielinski, S.R. Pinnell (Durham, USA) |
| 15.18 | FC3.3 | Methacrylate and rubber glove allergies decrease dental personnel in Finland A. Alanko, K. Aalto-Korte, R. Jolanki (Helsinki, Finland) Methacrylate and rubber glove allergies decrease dental personnel in Finland A. Alanko, K. Aalto-Korte, R. Jolanki (Helsinki, Finland) |
| 15.27 | FC3.4 | Collagen neogenesis after radiofrequency with vacuum apparatus skin treatment. M. Gold, B. Zelickson, D. Kist, M. Goldman, J. Counters, D. Mehregan (Tennessee, USA) |
| 15.36 | FC3.5 | Fractional visible light skin therapy: First clinical results. I. De Felipe, P. Redondo, F. Leal (Madrid, Spain) |
| 15.45 | FC3.6 | Effect of cold air cooling on the incidence of postinflammatory hyperpigmentation following a Q- switched Nd: YAG laser treatment of Hori’s nevus. W. Manuskiatti, S. Eimpunth, R. Wanitphakdeedecha (Bangkok, Thailand) |
| 15.54 | FC3.7 | Assessment of the film forming, protective and penetration-enhancing activity of water soluble biopolymers on ungual laminae. A. Sparavigna, F. Mailland, M. Setaro (Monza, Italy) |
| 16.03 | FC3.8 | How does nicotine influence inflammatory skin diseases? A. Hana, C. Fademrecht, G. Frongia, A. Gratchev, S. Goerdt, H. Kurzen (Mannheim, Germany) |
| 16.12 | FC3.9 | Severity scale of Cellulite. D. Hexsel, T. Dal´Forno, C. Hexsel (Porto Alegre, Brazil) |
| 16.21 | FC3.10 | Cellulite treatment combining broad spectrum infrared light and bipolar radiofrequency. D. Landwehr, D. Trumm (Saarbrücken, Germany) |
FC4 Atopic Dermatitis and Related
Friday, 18 May 2007
9.15 – 10.45 Hall J565
Chairs: P. Elias (San Francisco, USA), R. Jarisch (Vienna, Austria)
| 9.15 | FC4.1 | Randomised controlled trial in atopic dermatitis: Efficacy of out-patient synchronous balneophototherapy (sBPT) combining bathing in 10% dead sea salt solution plus narrowband UVB versus narrowband UVB alone. W. Stolz, M. Landthaler, J. Schiffner-Rohe, R. Schiffner (Munich, Germany) |
| 9.24 | FC4.2 | Efficacy and safety of tacrolimus 0.03% ointment (protopic) versus potent corticosteroid ointment as second line treatment in children with moderate to severe atopic dermatitis. N. Doss, M.R. Kamoun, L. Dubertret, F. Cambazard, A. Remitz, Y. De Prost (Tunis, Tunisia) |
| 9.33 | FC4.3 | A randomized, controlled trial of pimecrolimus cream 1% in children with head & neck atopic dermatitis and intolerant of, or dependent on topical corticosteroids. P. Hoeger, K.-H. Lee, J. Jautova, J. Wohlrab, A. Guettner, G. Mizutani (Hamburg, Germany) |
| 9.42 | FC4.4 | Skin barrier improvement after topical treatment with pimecrolimus versus betamethasone in atopic eczema. J.-M. Jensen, S. Pfeiffer, M. Witt, R. Fölster-Holst, C. Neumann, E. Proksch (Kiel, Germany) |
| 9.51 | FC4.5 | Emollients improve treatment results in childhood atopic dermatitis – a randomised comparative study J. Tymicka, A. Reich, J.C. Szepietowski (Wroclaw, Poland) |
| 10.00 | FC4.6 | Periorbital dermatitis – assessment of 102 patients. A. Lazarov (Kfar Saba, Israel) |
| 10.09 | FC4.7 | A randomized, controlled trial of pimecrolimus cream 1% in adults with perioral dermatitis. T. Schwarz, D. Thaci, M. Bräutigam (Kiel, Germany) |
| 10.18 | FC4.8 | “Eczemas” and leptin. N. Balato, G. Matarese, M. Nino, S.Fontana, A. Balato, F. Ayala (Naples, Italy) |
| 10.27 | FC4.9 | Loss-of-function mutations in the filaggrin gene predispose to early onset but not to adult onset atopic eczema. E. Greisenegger, A. Zimprich, F. Zimprich, M. Weber, G. Stingl, T. Kopp (Vienna, Austria) |
| 10.36 | FC4.10 | Activation of the interleukin-1beta-processing inflammasome is involved in contact hypersensitivity. H. Watanabe, O. Gaide, V. Petrilli, F. Martinon, S. Roques, E. Contassot, J. Tschopp, L. French (Geneva, Switzerland) |
FC5 Autoimmune Diseases
Friday, 18 May 2007
11.00 – 12.30 Hall J565
Chairs: A. Kobza Black (London, UK), A. Gorkiewicz-Petkow (Warsaw, Poland)
| 11.00 | FC5.1 | Measuring the immeasurable: A systematic review of outcome measures in pemphigus L.K. Martin, D.F.Murrell (Sydney, Australia) |
| 11.09 | FC5.2 | Pemphigus in pregnancy: A therapeutic dilemma A.J. Kanwar (Chandigarh, India) |
| 11.18 | FC5.3 | Successful treatment of Recalcitrant Pemphigus Foliaceus with Rituximab V. Serrão, A. Martins, F.R. Páris, M.J. Lopes (Lisbon, Portugal) |
| 11.27 | FC5.4 | CANCELLED |
| 11.36 | FC5.5 | Autoimmune progesterone dermatosis S. Medeiros, R. Rodrigues Alves, M. Costa, A. Afonso, A. Rodrigues, J. Cardoso (Lisbon, Portugal) |
| 11.45 | FC5.6 | Evaluation of a core set questionnaire for patients with cutaneous lupus erythematosus: Analysis of 40 patients in Germany and Sweden E. Kühn, M. Haust, V. Werth, F. Nyberg, A. Kuhn (Düsseldorf, Germany) |
| 11.54 | FC5.7 | Unilateral discoid lupus erythematosus: Case report and review of the literature K.D. Nomikos, I. Chaniotakis, C. Stergiopoulou, D. Kiorpelidou, D. Bassukas (Ioannina, Greece) |
| 12.03 | FC5.8 | Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy M. Dörler, N.S. Tomi, M. Huger, P. Altmeyer, T. Gambichler, A. Kreuter (Bochum, Germany) |
| 12.12 | FC5.9 | Paraneoplastic dermatomyositis: Retrospective study of 20 cases J.M. Sanchez-Schmidt, A. Jucglà-Serra, C. Prat, R. Pujol-Vallverdú (Barcelona, Spain) |
| 12.21 | FC5.10 | Selective immunosuppression with BCX-4208: A novel treatment approach for psoriasis & autoimmune diseases A. Gaweco, S. Navé, M. Kilpatrick, S. Bantia (Nutley, USA) |
FC6 Infectious Disease 1
Friday, 18 May 2007
15.00 – 17.00 Hall H
Chairs: R. Höpfl (Innsbruck, Austria), H. Schöfer (Frankfurt, Germany)
| 15.00 | FC6.1 | Efficacy of azithromycin versus systemic meglumune antimonate (glucantime) in the treatment of cutaneous leishmaniasis P. Layegh, M.J. Yazdan Panah, E. Mohammadi Vosugh (Mashad, Iran) |
| 15.09 | FC6.2 | Miltfesone for the treatment of American leishmaniasis S. Wöhrl, J. Schnedl, H. Auer, J. Walochnik, G. Stingl, A. Geusau (Vienna, Austria) |
| 15.18 | FC6.3 | The comparison between trichloroacetic acid 50% and co2 laser in treatment of cutaneous leishmaniasis M.A. Nilforoushzadeh, F. Jaffary, N. Ansari, S. Moradi (Teheran, Iran) |
| 15.27 | FC6.4 | Lymphatic filariasis in Tigray, Ethiopia M. Terranova, V. Padovese, A. Morrone (Rome, Italy) |
| 15.36 | FC6.5 | Paracoccidioidomycosis diagnosed in europe: A public health problem in non-endemic areas F. Guimera-Martin-Neda, M. Sidro, N. Perez-Robayna, S. Gonzalez, M. Garcia-Bustinduy, E. Fagundo, M. Sáez, A. Noda, R. Sanchez-Gonzalez (Santa Cruz de Tenerife, Spain) |
| 15.45 | FC6.6 | Microsporum canis infections in Vienna 1988 – 2005 C. Messeritsch, M. Haller, C. Heller-Vitouch, A. Stary (Vienna, Austria) |
| 15.54 | FC6.7 | CANCELLED |
| 16.03 | FC6.8 | The study on changes of Langerhans cell and its mechanisms in condyloma accuminatum lesions Y. Pan, D. Luo, F. Wang (Nanjing, China) |
| 16.12 | FC6.9 | Staphylococcus aureus resistance to topical fusidic acid in an Irish paediatric population M.A. Mc Aleer, E. Allen, C. O' Neill, M. Cafferkey, B. O' Donnell (Dublin, Ireland) |
| 16.21 | FC6.10 | Clinical and etiological study of sepsis in dermatology ward V. Sharma, D. Asati, A. Kapil, G. Khilnani (New Delhi, India) |
| 16.30 | FC6.11 | Necrotizing fasciitis, betadine and hypothyroidism A. Rao, M. Iqbal, D. Price, J. Stephens (Swansea, UK) |
| 16.39 | FC6.12 | Human demodex folliculorum infection and environmental factors S.R. Gotia, P. Ghitulescu, S.L. Gotia, C. Borza, D. Crisnic (Timisoara, Romania) |
| 16.48 | FC6.13 | CANCELLED |
FC7 Pigmentary Changes and Melanoma
Friday, 18 May 2007
15.00 – 17.00 Hall I
Chairs: W. Jurecka (Vienna, Austria), C. Garbe (Tübingen, Germany)
| 15.00 | FC7.1 | Sentinel node biopsy in cutaneous melanoma: Correlations between melanoma prognostic factors and sentinel node status E. Minutilli, M. Anzà, R. Garinei, P. Perri, C. Botti, L. Piarulli, P. Bruno, S. Rea, P. Visca, M. Mottolese, D. Giannarelli, S. Di Filippo, F. Di Filippo (Rome, Italy) |
| 15.09 | FC7.2 | Multimarker real-time RT-PCR for quantitative detection of melanoma associated antigens, a possible novel staging method P. Arenberger, M. Arenbergerova, S. Gkalpakiotis, J. Lippert, J. Kremen (Prague, Czech Republic) |
| 15.18 | FC7.3 | Molecular profiling of cutaneous melanoma and functional characterization of ASK/Dbf4 upregulation S.R. Nambiar, A. Mirmohammadsadegh, M. Hassan, A. Marini, A. Alaoui, J.H. Hegemann, U.R. Hengge (Düsseldorf, Germany) |
| 15.27 | FC7.4 | Melanoma screening with cellular phones C. Massone, R. Hofmann-Wellenhof, V. Ahlgrimm-Siess, G. Gabler, C. Ebner, H.P. Soyer (Graz, Austria) |
| 15.36 | FC7.5 | An audit of two weeks skin cancer referrals A.S. Alkali, P. Banerjee (London, UK) |
| 15.45 | FC7.6 | Melanocytic epithelioid cells nevus of the thigh: A new simulator of melanoma P. Donati, L.M. Muscardin, C. Panetta, A. Amantea (Rome, Italy) |
| 15.54 | FC7.7 | Pathogenesis of skin pigmentation in pityriasis versicolour A. Al-Dulaimi (Kidbrooke, UK) |
| 16.03 | FC7.8 | Hypopigmented type of vitiligo before and after puva: Clinical, histopathological, immunohistochemical, and ultrastructural study T.S. Anbar, A. El-Sawy, S. Attia, N. Moftah, M.H. El-Tonsy (Al- Minya, Egypt) |
| 16.12 | FC7.9 | CANCELLED |
| 16.21 | FC7.10 | PUVA and NBUVB in inducing stability in vitiligo, assessed by VIDA scoring - a comparative study D. Parsad, A. Bhatnagar, A. Kanwar, D. De (Chandigarh, India) |
| 16.30 | FC7.11 | Epithelial grafting for vitiligo requires uva phototherapy to guarantee success S. Awad, A. Abdelraof, M. El-Domyati (Minia, Egypt) |
| 16.39 | FC7.12 | Split grafting in the vitiligo surgery: A study in 600 patients D. Siddhartha Sankar (Kolkata, India) |
| 16.48 | FC7.13 | Melanocortin 1 receptor gene variants and skin colour measured by reflectance spectrophotometry in French Caucasian middle-aged women J. Latreille, A. Elfakir, K. Ezzedine, S. Gardinier, L. Ambroisine, P. Galan, S. Hercberg, E. Tschachler, C. Guinot (Neuilly sur Seine, France) |
FC8 Hereditary Diseases and Related
Friday, 18 May 2007
15.00 – 16.30 Hall J565
Chairs: J. Bauer (Salzburg, Austria), G. Zambruno (Roma, Italy)
| 15.00 | FC8.1 | Differential expression of pyloric atresia in junctional epidermolysis bullosa with novel ITGB4 mutations N. Dang, S. Klingberg, A.I. Rubin, M. Edwards, S. Borelli, J. Relic, P. Marr, K. Tran, A. Turner, N. Smith, D. F. Murrell (Sydney, Australia) |
| 15.09 | FC8.2 | The molecular diagnostic in dystrophic epidermolysis bullosa S. Danescu, R. Cosgarea, C. Has, L. Bruckner-Tuderman (Cluj Napoca, Romania) |
| 15.18 | FC8.3 | N-terminal mutation in LAMA3A isoform causing Herlitz junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome D.F. Murrell, K.J. Hamill, J. Uitto, E. Figueira, A. Crotty, K. Moran, L. Lloyd, S. Klingberg, W.H.I McLean (Sydney, Australia) |
| 15.27 | FC8.4 | Gerodermia Osteodysplastica (GO)/ Wrinkly Skin Syndrome (WSS)/ Cutis Laxa with Growth and Developmental Delay (CLGDD) A. Nanda (Al-Sabah, Kuwait) |
| 15.36 | FC8.5 | Collodion Baby outcome in 121 cases: 35 years retrospective study M. Larregue, G. Guillet, M.A. Ionescu, C. Bieder (Paris, France) |
| 15.45 | FC8.6 | Fibroblast growth factor receptor 3 mutations in non-epidermolytic keratinocytic epidermal nevi and associated low grade bladder tumours A. Toll, A. Fernandez-Casado, S. Hernández, E. Baselga, A. Ribé, J. Azua-Romeo, R.M. Pujol, F.X. Real (Barcelona, Spain) |
| 15.54 | FC8.7 | HLA-C and HCR genes association with psoriasis in Russian populations E. Galimova, V. Akhmetova, E. Khusnutdinova (Ufa, Russia) |
| 16.03 | FC8.8 | The methylation pattern of P16INK4a gene promoter in epidermis and its significance in psoriasis M. Chen, Z.-Q. Chen, A.-S. Li , J.-Q. Gong, X. Yao (Nanjing, China) |
| 16.12 | FC8.9 | Two patients with Epidermodysplasia verruciformis: Two different patterns R. Tiberio, M. Gariglio, B. Azzimonti, U. Dianzani, E. Zavattaro, G. Cappellano, G. Pertusi, E. Colombo, G. Leigheb (Novara, Italy) |
| 16.21 | FC8.10 | Sweet-like skin lesions in a patient with Familial Mediterranean Fever (FMF): Co-morbidity or a cutaneous feature of FMF? T. Oskay, E. Sarifakioglu, R. Anadolu Brasie (Ankara, Turkey) |
FC9 Infectious diseases 2
Saturday, 19 May 2007
8.30 – 10.00 Hall K
Chairs: A. Geusau (Vienna, Austria), J. Söltz-Szöts (Vienna, Austria)
| 8.30 | FC9.1 | High response rates of AIDS related Kaposi’s sarcoma to suppressive haart and short-term liposomal doxorubicin N. Kohrgruber, A. Rieger, E. Tschachler (Vienna, Austria) |
| 8.39 | FC9.2 | Skin lesions in HIV/AIDS patients, our experience in Tigray, Ethiopia M. Terranova, V. Padovese, A. Morrone (Rome, Italy) |
| 8.48 | FC9.3 | Evidence based integrated treatment for Lymphatic Filariasis, Vitiligo and HIV/AIDS S.R.B. Narahari, T.J. Ryan, B. Naresh, K. Prasanna, P. Mahadevan, K. Bose (Kasaragod, India) |
| 8.57 | FC9.4 | Syphilis epidemiology for the previous 60 years D.V. Zaslavsky, B.N. Nikiforov, O.V. Olovyanishnikov (St. Petersburg, Russia) |
| 9.06 | FC9.5 | Virus-associated hemophagocytic syndrome presenting as exfoliative dermatitis – case report Z. Gajinov, M. Matic, M. Ivkov-Simic, N. Rajic, V. Djuran, M. Poljacki (Novi Sad, Serbia and Montenegro) |
|
9.15 |
FC9.6 | CANCELLED |
| 9.24 | FC9.7 | Efficacy of granulocyte and monocyte adsorption apheresis for refractory skin diseases M. Seishima, Y. Mizutani, Y. Shibuya, C. Arakawa, T. Aoki (Ogaki City, Japan) |
| 9.33 | FC9.8 | Tinea capitis in the elderly W. Weger, G. Ginter-Hanselmayer (Graz, Austria) |
| 9.42 | FC9.9 | Topical 10% zinc sulfate solution in the treatment of superficial fungal infections K.E. Sharquie, A.A. Al-Nuaimy, I.G. Al-Tereihi, I.K. Sharquie (Baghdad, Iraq) |
| 9.51 | FC9.10 | Pregnant adolescents and C. trachomatis infection: Prevalence and diagnostic challenges C. João, D. Domingues, R. Castro, F. Exposto (Lisbon, Portugal) |
FC10 Miscellaneous
Saturday, 19 May 2007
10.15 – 11.45 Hall K
Chairs: D. Fanta (Steyr, Austria), G.S. Tiplica (Bucharest, Romania)
| 10.15 | FC10.1 | European survey on working conditions 2000, and skin problems M. de Carli (Treviso, Italy) |
| 10.24 | FC10.2 | CANCELLED |
| 10.33 | FC10.3 | Negative predictive value of skin tests for investigating cutaneous adverse drug reactions J. Waton, P. Trechot, J.L. Schmutz, J.F. Cuny, A. Barbaud (Nancy, France) |
| 10.42 | FC10.4 | Convergent and discriminant validity of quality of life measures, Turkish skindex-29 and short form 36, in patients with skin disease A.E. Koku Aksu, M. Tozun (Eskisehir, Turkey) |
| 10.51 | FC10.5 | Influence of Statum conreum pH gradient on the neonatal development of barrier-related skin physiology and dermal fibre network: Implications for skin care J.W. Fluhr, M. Breternitz, S. Zimmermann, J. Koehler, M. Kaatz, P. Elsner, Skin Physiology Laboratory (Jena, Germany) |
| 11.00 | FC10.6 | Cerebral processing of histamine-induced itch with short term low intensitity temperature modulation – an fMRI study F. Pfab, M. Valet, T. Sprenger, T.R. Tölle, C. Zimmer, H. Behrendt, J. Ring, U. Darsow (Munich, Germany) |
| 11.09 | FC10.7 | Fast onset of action of Rupatadine 10- and 20 mg in the reduction of pruritus in patients suffering from chronic urticaria A. Giménez-Arnau, S. Ianosi, A. Kaszuba, L. Zalupca, T. Cristodoulo, I. Pérez, E. Arnaiz (Barcelona, Spain) |
| 11.18 | FC10.8 | Darier’s sign: A clinical indicator of cutaneous mast cell infiltrations D. Kiorpelidou, C. Fotika, I. Alexis, G. Tsiouri, I.D. Bassukas (Ioannina, Greece) |
| 11.27 | FC10.9 | Apoptosis and DNA repair markers in aged human testes M. El-Domyati, A. Al-Din, M. Barakat, H. El-Fakahany, J. Xu, D. Sakkas (Al-Minya, Egypt) |
| 11.36 | FC10.10 | Striking reduction of terminal Schwann cells and nerve fiber length in the subepidermal nerve plexus of diabetic patients compared to non-diabetic controls C. Reinisch, H. Traxler, S. Piringer, S. Tang, A. Nader, E. Tschachler (Vienna, Austria) |
FC11 Lymphoma
Saturday, 19 May 2007
13.00 – 14.30 Hall K
Chairs: C. Minghua (Shanghai, China), F. Trautinger (Vienna, Austria)
| 13.00 | FC11.1 | Comparison of narrowband uvb and psoralen-uva in the treatment of early-stage mycosis fungoides: A retrospective study S. Cikman Toke, E. Bulbul Baskan, S. Tunali, H. Saricaoglu (Bursa, Turkey) |
| 13.09 | FC11.2 | The role of apoptosis and cell proliferation regulating genes in mycosis fungoides L. Kandolf Sekulovic, B. Cikota, M. Jovic, J. Basanovic, D. Skiljevic, L. Medenica, M. Pavlovic, Z. Magic (Belgrade, Serbia and Montenegro) |
| 13.18 | FC11.3 | Mycosis fungoides of the oral mucosa: A case report and review of the literature K. Balighi, S. Toosi, Z.S. Naraghi, H. Vaziri (Tehran, Iran) |
| 13.27 | FC11.4 | CANCELLED |
| 13.36 | FC11.5 | Mycosis fungoides tumour stage- good therapeutic response- case report S. Tanasilovic, D. Zivanovic, L. Medenica (Belgrade, Serbia and Montenegro) |
| 13.45 | FC11.6 | A case report of mixed panniculitis following interferon therapy for mycosis fungoides H. Vaziri, Z. Naraghi, K. Balighi, P. Rahimi (Tehran, Iran) |
| 13.54 | FC11.7 | Cutaneous lesions as the first manifestation of systemic follicular lymphoma E. Moreira, C. Lisboa, S. Alves, I. Moreira, E. Fonseca, J. Lopes, F. Azevedo (Porto, Portugal) |
| 14.03 | FC11.8 | Primary cutaneous large b-cell lymphoma. Histopathological, immunophenotypical and genetic study of 40 patients E. Parera, F. Gallardo, J. Sánchez, M. García,C. Barranco, R. Salgado, S. Giménez, B. Espinet, A. García, T. Estrach, O. Servitje, P. García-Muret, R.M. Pujol (Barcelona, Spain) |
| 14.12 | FC11.9 | Langerhans cell histiocytosis – review of 6 cases D. Zivanovic, S. Tanasilovic, M.M. Nikolic, M. Gajic- Veljic, K. Djukic, M. Mijuskovic, L. Medenica (Belgrade, Serbia and Montenegro) |
| 14.21 | FC11.10 | Primary cutaneous lymphoblastic lymphoma: Description of 5 cases P. Vezzoli, S. Muratori, L. Venegoni, D. Fanoni, E. Alessi, E. Berti (Milan, Italy) |
FC12 Wound Healing and Miscellaneous
Saturday, 19 May 2007
13.00 – 14.30 Hall L & M
Chairs: A. Steiner (Vienna, Austria), W. Gebhart (St. Pölten, Austria)
| 13.00 | FC12.1 | Tele wound care in patients with chronic ulcers B. Binder, R. Hofmann-Wellenhof, W. Salmhofer, A. Okcu, H. Kerl, H.P. Soyer (Graz, Austria) |
| 13.09 | FC12.2 | Efficacy of amniotic membrane transplantation in the treatment of leg ulcers I. Mermet, S. Cairey-Remonnay, N. Pottier, J.M. Sainthillier, C. Malugani, S. Maddens, D. Riethmuller, P. Tiberghien, P. Humbert, F. Aubin (Besançon) |
| 13.18 | FC12.3 | Evaluation of the efficacy of a new compression system for the treatment of venous leg ulcers J. Strejcek (Prague, Czech Republic) |
| 13.27 | FC12.4 | Clinical comparison of phenytoin sodium and calendula in open wound healing D. Behzadpour (Rasht, Iran) |
| 13.36 | FC12.5 | CANCELLED |
| 13.45 | FC12.6 | Urticarial vasculitis due to infliximab J. Goulao, H. Cunha, I. Anes, E. Bartolo, C. Furtado, P. Serrano, F.M. Brandao (Almada, Portugal) |
| 13.54 | FC12.7 | Epidemiological study of lymphoedema of young population J. Delic, Z. Jovanovic (Belgrade, Serbia and Montenegro) |
| 14.03 | FC12.8 | Comparison of different surgical techniques in the treatment of pincer nails S. Lauchli, J. Hafner, R. Baran, L. French (Zurich, Switzerland) |
| 14.12 | FC12.9 | Childhood alopecia areata: A study of 54 patients S. Dogan, S. Ersoy Evans, S. Şahin (Ankara, Turkey) |
| 14.21 | FC12.10 | How efficient is the pulse corticotherapy in alopecia areata? R. Cosgarea, S. Senila, I. Baldea, A. Crisan, L. Colibaba |
